Mar 12, 2025 · What is dolutegravir and lamivudine? Dolutegravir and lamivudine (Dovato) is a combination antiviral medication used to treat HIV-1 infection in adults and adolescents. This …

Apr 3, 2025 · Dolutegravir is an antiviral medicine that is used with other medications to treat HIV, the virus that can cause the acquired immunodeficiency syndrome (AIDS). Dolutegravir is not …

Dovato (dolutegravir/lamivudine) is commonly used for HIV-1. Learn more about HIV Treatment With Dovato. Dovato may also be used for other conditions as determined by your healthcare …

DOVATO is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 25 kg with no antiretroviral …

Apr 3, 2025 · US CDC Recommendations: 50 mg orally once a day Duration of therapy: 28 days Comments: This drug plus (emtricitabine-tenofovir disoproxil fumarate [DF] or …

Feb 10, 2020 · HIV-1 nonoccupational postexposure prophylaxis (nPEP) (off-label use): Oral: 50 mg once daily for 28 days (in combination with other antiretroviral agents). Initiate therapy …

Dolutegravir tablets 50 mg. FULL PRESCRIBING INFORMATION . 1 serious adverse events or loss of efficacy INDICATIONS AND USAGE . Dolutegravir tablets are indicated in combination …

Mar 6, 2024 · Dolutegravir (brand names: Tivicay and Tivicay PD) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in …

Get medical help right away if you develop symptoms of worsening liver problems. This product contains 2 drugs: dolutegravir and lamivudine. It is used to help control HIV infection. It helps …

Dolutegravir is an antiretroviral medication used to treat human immunodeficiency virus type-1 (HIV-1) infection in adults and children.